bioAffinity Technologies, Inc. (BIAF) News
Track canonical SquawkNews coverage tagged to BIAF, bioAffinity Technologies, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
bioAffinity Technologies prices $4M ATM private placement with warrants
bioAffinity Technologies (BIAF) prices a ~$4.0M-at-gross private placement at-the-market selling 8.46M shares (or pre-funded warrants) plus warrants for up to 16.9M more shares, with warrants struck at $0.4727.
EQUITY | Aug 13, 2026, 01:12 PM UTC
L
BIAF bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early
BIAF bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
EQUITY | Jul 27, 2026, 12:08 PM UTC
H
BIAF: Positive Preclinical Findings
BIAF bioAffinity Technologies reports positive preclinical findings showing proprietary gene silencing technology is selectively cytotoxic to squamous skin cancer cells without harming healthy cells
EQUITY | Jun 22, 2026, 12:00 PM UTC
L
BIAF Raises $3.2M
bioAffinity Technologies announces closing of $3.2 million offering
EQUITY | Jun 18, 2026, 05:19 PM UTC